VYNE Therapeutics
VYNE
VYNE
106 hedge funds and large institutions have $160M invested in VYNE Therapeutics in 2020 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 58 increasing their positions, 11 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.09% less ownership
Funds ownership: 0.79% → 0.7% (-0.09%)
Holders
106
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$28.1M | |
| 2 | +$11.7M | |
| 3 | +$10.9M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.3M |
| 5 |
BlackRock
New York
|
+$9.08M |
Top Sellers
| 1 | -$4.43M | |
| 2 | -$3.92M | |
| 3 | -$2.83M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.68M |
| 5 |
O
OrbiMed
New York
|
-$2M |